Literature DB >> 35058599

The clinician's guide to randomized trials: interpretation.

Alex Thabane1, Mark R Phillips1, Tien Y Wong2, Lehana Thabane1,3, Mohit Bhandari1,4, Varun Chaudhary5,6.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35058599      PMCID： PMC8873262          DOI： 10.1038/s41433-021-01866-7

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

Review 1.  Eyes or subjects: are ophthalmic randomized controlled trials properly designed and analyzed?

Authors:  Chun Fan Lee; Andy Chi On Cheng; Daniel Yee Tak Fong
Journal:  Ophthalmology       Date:  2012-01-09       Impact factor: 12.079

Review 2.  The reporting quality of parallel randomised controlled trials in ophthalmic surgery in 2011: a systematic review.

Authors:  A C Yao; A Khajuria; C F Camm; E Edison; R Agha
Journal:  Eye (Lond)       Date:  2014-09-12       Impact factor: 3.775

3.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

Review 4.  The Effect of Technical Performance on Patient Outcomes in Surgery: A Systematic Review.

Authors:  Andras B Fecso; Peter Szasz; Georgi Kerezov; Teodor P Grantcharov
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

5.  Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review.

Authors:  Mali Okada; Paul Mitchell; Robert P Finger; Bora Eldem; S James Talks; Ceri Hirst; Luciano Paladini; Jane Barratt; Tien Yin Wong; Anat Loewenstein
Journal:  Ophthalmology       Date:  2020-08-05       Impact factor: 12.079

6.  Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.

Authors:  David M Brown; Charles C Wykoff; David Boyer; Jeffrey S Heier; W Lloyd Clark; Andres Emanuelli; Patrick M Higgins; Michael Singer; David M Weinreich; George D Yancopoulos; Alyson J Berliner; Karen Chu; Kimberly Reed; Yenchieh Cheng; Robert Vitti
Journal:  JAMA Ophthalmol       Date:  2021-09-01       Impact factor: 7.389
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.